Tema Heart & Health ETF (NASDAQ:HRTS) Short Interest Down 50.8% in August

Tema Heart & Health ETF (NASDAQ:HRTS) was the recipient of a large drop in short interest in the month of August. As of August 14th, there was short interest totaling 2,508 shares, a drop of 50.8% from the July 30th total of 5,095 shares. Based on an average daily volume of 3,207 shares, the short-interest ratio is presently 0.8 days. Approximately 0.2% of the company’s shares are sold short.

Institutional Trading of Tema Heart & Health ETF

Several large investors have recently bought and sold shares of the company. Stifel Financial Corp grew its stake in Tema Heart & Health ETF by 19.8% in the fourth quarter. Stifel Financial Corp now owns 33,647 shares of the company’s stock worth $1,187,000 after purchasing an additional 5,571 shares during the period. Citadel Advisors LLC purchased a new position in Tema Heart & Health ETF during the third quarter valued at $243,000. Jane Street Group LLC lifted its position in Tema Heart & Health ETF by 9.4% during the second quarter. Jane Street Group LLC now owns 37,164 shares of the company’s stock valued at $1,062,000 after buying an additional 3,202 shares during the period. JPMorgan Chase & Co. purchased a new position in Tema Heart & Health ETF during the second quarter valued at $63,000. Finally, Anson Capital Inc. bought a new stake in shares of Tema Heart & Health ETF during the 2nd quarter valued at $297,000.

Tema Heart & Health ETF Stock Down 1.1%

Shares of HRTS traded down $0.42 during trading hours on Friday, reaching $37.64. 3,797 shares of the company traded hands, compared to its average volume of 5,984. Tema Heart & Health ETF has a 12 month low of $29.45 and a 12 month high of $38.87. The company’s fifty day moving average price is $36.89 and its two-hundred day moving average price is $35.15. The company has a market capitalization of $56.08 million, a price-to-earnings ratio of 22.06 and a beta of 0.63.

About Tema Heart & Health ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.